Literature DB >> 28704644

Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.

Shanshan Jiang1, Charles G Eberhart2, Yi Zhang3, Hye-Young Heo3, Zhibo Wen4, Lindsay Blair5, Huamin Qin2, Michael Lim6, Alfredo Quinones-Hinojosa6, Jon D Weingart6, Peter B Barker3, Martin G Pomper3, John Laterra7, Peter C M van Zijl8, Jaishri O Blakeley9, Jinyuan Zhou10.   

Abstract

PURPOSE: Pathological assessment using World Health Organization (WHO) criteria is the gold standard for diagnosis of gliomas. However, the accuracy of diagnosis is limited by tissue sampling, particularly for infiltrating, heterogeneous tumours. We assessed the accuracy of amide proton transfer-weighted (APTw) magnetic resonance imaging (MRI)-guided tissue sampling to identify regions of high-grade glioma via radiographic-histopathologic correlation in patients with newly suspected glioma. PATIENTS AND METHODS: Twenty-four patients with previously undiagnosed gliomas underwent a volumetric APTw MRI prior to their first neurosurgical procedure. A total of 70 specimens were collected via APTw image-directed stereotactic biopsy. Cellularity, necrosis, proliferation and glioma WHO grade were analysed for all specimens and correlated with corresponding APTw signal intensities.
RESULTS: Thirty-three specimens displayed grade-II pathology, 14 grade-III, 15 grade-IV, and eight specimens revealed only peritumoural oedema. Multiple glioma grades were found within a single lesion in six patients. APTw signal intensities of the biopsied sites and the maximum APTw values across all biopsied sites in each patient were significantly higher for high-grade versus low-grade specimens. APTw signal intensities were significantly positively correlated with cellularity (R = 0.757) and proliferation (R = 0.538). Multiple linear regression analysis showed that tumour cellularity and proliferation index were the best predictors of APTw signal intensities.
CONCLUSION: APTw imaging identified tumour areas of higher cellularity and proliferation, allowing identification of high-grade regions within heterogeneous gliomas. APTw imaging can be readily translated for more widespread use and can assist diagnostic neurosurgical procedures by increasing the accuracy of tumour sampling in patients with infiltrating gliomas.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amide proton transfer-weighted imaging; Glioma; Histopathologic validation; Image-guided biopsy; Imaging biomarker

Mesh:

Substances:

Year:  2017        PMID: 28704644      PMCID: PMC5572540          DOI: 10.1016/j.ejca.2017.06.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  37 in total

Review 1.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

2.  The clinical utility of multimodal MR image-guided needle biopsy in cerebral gliomas.

Authors:  Chengjun Yao; Shunzeng Lv; Hong Chen; Weijun Tang; Jun Guo; Dongxiao Zhuang; Nikos Chrisochoides; Jinsong Wu; Ying Mao; Liangfu Zhou
Journal:  Int J Neurosci       Date:  2015-01-07       Impact factor: 2.292

3.  Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging.

Authors:  Antonio C M Maia; Suzana M F Malheiros; Antonio J da Rocha; João N Stávale; Iara F Guimarães; Lia R R Borges; Adrialdo J Santos; Carlos J da Silva; Julieta G S P de Melo; Oreste P Lanzoni; Alberto A Gabbai; Fernando A P Ferraz
Journal:  J Neurosurg       Date:  2004-12       Impact factor: 5.115

4.  A new method for detecting exchanging amide protons using chemical exchange rotation transfer.

Authors:  Zhongliang Zu; Vaibhav A Janve; Junzhong Xu; Mark D Does; John C Gore; Daniel F Gochberg
Journal:  Magn Reson Med       Date:  2012-04-13       Impact factor: 4.668

5.  Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.

Authors:  Ramon F Barajas; Joanna J Phillips; Rupa Parvataneni; Annette Molinaro; Emma Essock-Burns; Gabriela Bourne; Andrew T Parsa; Manish K Aghi; Michael W McDermott; Mitchel S Berger; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

6.  Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.

Authors:  Akihiko Sakata; Tomohisa Okada; Akira Yamamoto; Mitsunori Kanagaki; Yasutaka Fushimi; Tsutomu Okada; Toshiki Dodo; Yoshiki Arakawa; Benjamin Schmitt; Susumu Miyamoto; Kaori Togashi
Journal:  J Neurooncol       Date:  2015-01-06       Impact factor: 4.130

7.  Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.

Authors:  Adrienne N Dula; Lori R Arlinghaus; Richard D Dortch; Blake E Dewey; Jennifer G Whisenant; Gregory D Ayers; Thomas E Yankeelov; Seth A Smith
Journal:  Magn Reson Med       Date:  2012-08-20       Impact factor: 4.668

8.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Dong-Hoon Lee; Xiaohua Hong; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-03-05       Impact factor: 4.668

9.  APT-weighted and NOE-weighted image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses.

Authors:  Jinyuan Zhou; Xiaohua Hong; Xuna Zhao; Jia-Hong Gao; Jing Yuan
Journal:  Magn Reson Med       Date:  2013-05-09       Impact factor: 4.668

10.  Histopathological correlates with survival in reoperated glioblastomas.

Authors:  Graeme F Woodworth; Tomas Garzon-Muvdi; Xiaobu Ye; Jaishri O Blakeley; Jon D Weingart; Peter C Burger
Journal:  J Neurooncol       Date:  2013-05-11       Impact factor: 4.130

View more
  32 in total

1.  Prospective acceleration of parallel RF transmission-based 3D chemical exchange saturation transfer imaging with compressed sensing.

Authors:  Hye-Young Heo; Xiang Xu; Shanshan Jiang; Yansong Zhao; Jochen Keupp; Kristin J Redmond; John Laterra; Peter C M van Zijl; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2019-06-17       Impact factor: 4.668

2.  Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.

Authors:  Shanshan Jiang; Qihong Rui; Yu Wang; Hye-Young Heo; Tianyu Zou; Hao Yu; Yi Zhang; Xianlong Wang; Yongxing Du; Xinrui Wen; Fangyao Chen; Jihong Wang; Charles G Eberhart; Jinyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

3.  Quantifying amide proton exchange rate and concentration in chemical exchange saturation transfer imaging of the human brain.

Authors:  Hye-Young Heo; Zheng Han; Shanshan Jiang; Michael Schär; Peter C M van Zijl; Jinyuan Zhou
Journal:  Neuroimage       Date:  2019-01-14       Impact factor: 6.556

4.  Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging.

Authors:  Lu Yu; Chunmei Li; Xiaojie Luo; Jinyuan Zhou; Chen Zhang; Yi Zhang; Min Chen
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

5.  Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.

Authors:  Tianyu Zou; Hao Yu; Chunxiu Jiang; Xianlong Wang; Shanshan Jiang; Qihong Rui; Yingjie Mei; Jinyuan Zhou; Zhibo Wen
Journal:  NMR Biomed       Date:  2017-11-03       Impact factor: 4.044

6.  Influences of experimental parameters on chemical exchange saturation transfer (CEST) metrics of brain tumors using animal models at 4.7T.

Authors:  Hye-Young Heo; Yi Zhang; Shanshan Jiang; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2018-08-19       Impact factor: 4.668

7.  Endogenous Chemical Exchange Saturation Transfer MRI for the Diagnosis and Therapy Response Assessment of Brain Tumors: A Systematic Review.

Authors:  Sachi Okuchi; Ahmed Hammam; Xavier Golay; Mina Kim; Stefanie Thust
Journal:  Radiol Imaging Cancer       Date:  2020-01-31

8.  Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Ji Eun Park; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim; Ho Sung Kim
Journal:  Neuroradiology       Date:  2019-01-21       Impact factor: 2.804

9.  Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.

Authors:  Shanshan Jiang; Charles G Eberhart; Michael Lim; Hye-Young Heo; Yi Zhang; Lindsay Blair; Zhibo Wen; Matthias Holdhoff; Doris Lin; Peng Huang; Huamin Qin; Alfredo Quinones-Hinojosa; Jon D Weingart; Peter B Barker; Martin G Pomper; John Laterra; Peter C M van Zijl; Jaishri O Blakeley; Jinyuan Zhou
Journal:  Clin Cancer Res       Date:  2018-10-26       Impact factor: 12.531

10.  Amide proton transfer-weighted MRI for predicting histological grade of hepatocellular carcinoma: comparison with diffusion-weighted imaging.

Authors:  Yue Lin; Xiaojie Luo; Lu Yu; Yi Zhang; Jinyuan Zhou; Yuwei Jiang; Chen Zhang; Jintao Zhang; Chunmei Li; Min Chen
Journal:  Quant Imaging Med Surg       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.